What is idiopathic intracranial hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Idiopathic Intracranial Hypertension?

Idiopathic intracranial hypertension (IIH) is a disorder of elevated intracranial pressure without hydrocephalus, mass lesion, or identifiable underlying cause, characterized by normal cerebrospinal fluid composition and occurring predominantly in obese women of childbearing age. 1

Definition and Diagnostic Criteria

IIH represents raised intracranial pressure where no secondary etiology can be identified after thorough investigation. 1 The diagnosis requires:

  • Elevated intracranial pressure documented by lumbar puncture with opening pressure ≥25 cm H₂O (≥250 mm H₂O) measured in the lateral decubitus position with the patient relaxed and legs extended 2
  • Neuroimaging showing no evidence of hydrocephalus, mass, structural or vascular lesion, and no abnormal meningeal enhancement 2
  • Normal cerebrospinal fluid composition 1
  • Exclusion of cerebral sinus thrombosis via CT or MR venography 2

Epidemiology and Risk Factors

The annual incidence is increasing and was reported at 2.4 per 100,000 in the last decade (2002-2014). 1

The typical IIH patient is female, of childbearing age, with BMI >30 kg/m², and recent weight gain of 5-15% in the year preceding diagnosis. 2, 3 These three factors—female sex, obesity, and recent weight gain—define the classic patient profile. 3

Weight gain of 5-15% is the most important modifiable risk factor, and weight regain after initial loss is a major risk factor for disease recurrence throughout life. 3

Clinical Presentation

Headache is the most common presenting symptom, typically progressively more severe and frequent, though the phenotype is highly variable and may mimic other primary headache disorders. 1, 2 This variability makes clinical diagnosis challenging. 2

Additional symptoms include:

  • Transient visual obscurations (unilateral or bilateral darkening of vision lasting seconds) 1, 2
  • Pulsatile tinnitus (whooshing sound synchronous with pulse) 1, 2
  • Visual blurring 1, 2
  • Horizontal diplopia (typically from sixth nerve palsy) 1, 2
  • Back pain, neck pain, dizziness, cognitive disturbances, and radicular pain 1, 2

None of these symptoms are pathognomonic for IIH, meaning they can occur in other conditions. 2

Physical Examination Findings

Papilledema is the hallmark finding in IIH and should be documented. 2 On cranial nerve examination, there should typically be no cranial nerve involvement other than possible sixth nerve palsy. 2 If other cranial nerves or pathological findings are involved, alternative diagnoses should be considered. 2

A rare subtype called "IIH without papilledema" meets all other criteria for IIH but lacks papilledema, making diagnosis more difficult. 2

Pathophysiology

Although the underlying pathogenesis is not fully understood, IIH has a striking association with obesity. 1 Outflow resistance of cerebrospinal fluid is increased in IIH, requiring intracranial pressure to increase for CSF to be absorbed. 4 Pregnancy or hormonal changes may contribute to disease onset or recurrence, and the reproductive age window in women suggests hormonal influence on disease pathophysiology. 3

Management Principles

Three main treatment principles guide IIH management: 1

  1. Treat the underlying disease (primarily through weight loss as the disease-modifying treatment) 5
  2. Protect the vision (surgical intervention when visual function declines) 5
  3. Minimize headache morbidity 1

Prognosis and Complications

The main morbidity of IIH is visual loss, which is present in most patients and can usually be reversed if recognized early and treated. 4 Treatment failure rates for surgical interventions include worsening vision after initial stabilization in 34% of patients at 1 year and 45% at 3 years. 5 Failure to improve headache occurs in one-third to one-half of surgically treated patients. 5

Patients with IIH in ocular remission may still have ongoing headache morbidity requiring neurological management. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Idiopathic Intracranial Hypertension (IIH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risk Factors for Idiopathic Intracranial Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Idiopathic intracranial hypertension (pseudotumor cerebri).

Current neurology and neuroscience reports, 2008

Guideline

Management of Idiopathic Intracranial Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.